These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 29053029

  • 1. The evidence on effectiveness of weekly vs triweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis.
    Jacinto JK, Co J, Mejia MB, Regala EE.
    Br J Radiol; 2017 Nov; 90(1079):20170442. PubMed ID: 29053029
    [Abstract] [Full Text] [Related]

  • 2. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
    Mohamed A, Twardy B, Zordok MA, Ashraf K, Alkhoder A, Schrapp K, Steuer C, Chen Z, Pakkala S, Pillai R, Trad Wadsworth J, Higgins K, Beitler JJ, Ramalingam SS, Owonikoko TK, Khuri FR, Shin DM, Behera M, Saba NF.
    Head Neck; 2019 May; 41(5):1490-1498. PubMed ID: 30835900
    [Abstract] [Full Text] [Related]

  • 3. Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma.
    Morse RT, Ganju RG, TenNapel MJ, Neupane P, Kakarala K, Shnayder Y, Chen AM, Lominska CE.
    Head Neck; 2019 Aug; 41(8):2492-2499. PubMed ID: 30856297
    [Abstract] [Full Text] [Related]

  • 4. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
    Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Castro A, Licitra L, Adelstein D, Vermorken JB.
    Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
    [Abstract] [Full Text] [Related]

  • 5. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
    Fayette J, Molin Y, Lavergne E, Montbarbon X, Racadot S, Poupart M, Ramade A, Zrounba P, Ceruse P, Pommier P.
    Drug Des Devel Ther; 2015 Sep; 9():6203-10. PubMed ID: 26648696
    [Abstract] [Full Text] [Related]

  • 6. The comparison of acute toxicity in 2 treatment courses: Three-weekly and weekly cisplatin treatment administered with radiotherapy in patients with head and neck squamous cell carcinoma.
    Mackiewicz J, Rybarczyk-Kasiuchnicz A, Łasińska I, Mazur-Roszak M, Świniuch D, Michalak M, Kaźmierska J, Studniarek A, Krokowicz Ł, Bajon T.
    Medicine (Baltimore); 2017 Dec; 96(51):e9151. PubMed ID: 29390445
    [Abstract] [Full Text] [Related]

  • 7. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Ryu SY, Lee WM, Kim K, Park SI, Kim BJ, Kim MH, Choi SC, Cho CK, Nam BH, Lee ED.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e577-81. PubMed ID: 21840137
    [Abstract] [Full Text] [Related]

  • 8. [Cetuximab in head and neck squamous cell carcinoma: a systematic review and Meta-analysis].
    Song Q, Li X, Li B.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan 15; 29(1):67-75. PubMed ID: 25966559
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S, Yokota T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H.
    Jpn J Clin Oncol; 2015 Dec 15; 45(12):1116-21. PubMed ID: 26423341
    [Abstract] [Full Text] [Related]

  • 10. Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial.
    Rampino M, Ricardi U, Munoz F, Reali A, Barone C, Musu AR, Balcet V, Franco P, Grillo R, Bustreo S, Pecorari G, Cavalot A, Garzino Demo P, Ciuffreda L, Ragona R, Schena M.
    Clin Oncol (R Coll Radiol); 2011 Mar 15; 23(2):134-40. PubMed ID: 21030225
    [Abstract] [Full Text] [Related]

  • 11. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
    Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, D'Cruz AK, Banavali S, Pai PS, Chaturvedi P, Chaukar D, Pande N, Chandrasekharan A, Talreja V, Vallathol DH, Mathrudev V, Manjrekar A, Maske K, Bhelekar AS, Nawale K, Kannan S, Gota V, Bhattacharjee A, Kane S, Juvekar SL, Prabhash K.
    J Clin Oncol; 2018 Apr 10; 36(11):1064-1072. PubMed ID: 29220295
    [Abstract] [Full Text] [Related]

  • 12. Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    Wang K, Dong J, He S, Wang X, Jiang C, Hu P, Guo J, Cai X, Wang X.
    BMC Cancer; 2019 May 22; 19(1):482. PubMed ID: 31117967
    [Abstract] [Full Text] [Related]

  • 13. Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysis.
    Lee SY, Choi YS, Song IC, Park SG, Keam B, Yang YJ, Song EK, Lee HJ, Cho SH, Shim H, Park KU, Lee KH, Jo DY, Jo IS, Yun HJ, Korean South West Oncology Group (KSWOG) investigators.
    Medicine (Baltimore); 2018 May 22; 97(21):e10778. PubMed ID: 29794758
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis.
    Chen L, Li YC, Hu M, Zhao SJ, Yang QW.
    Medicine (Baltimore); 2022 Dec 30; 101(52):e31842. PubMed ID: 36596073
    [Abstract] [Full Text] [Related]

  • 15. Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02).
    Lee JY, Sun JM, Oh DR, Lim SH, Goo J, Lee SH, Kim SB, Park KU, Kim HK, Hong DS, Kim JS, Kim SG, Yi SY, Yun HJ, Hyun MS, Kim HJ, Jung SH, Park K, Ahn YC, Ahn MJ.
    Radiother Oncol; 2016 Feb 30; 118(2):244-50. PubMed ID: 26705681
    [Abstract] [Full Text] [Related]

  • 16. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
    Kinjyo Y, Nagai Y, Toita T, Kudaka W, Ariga T, Shimoji Y, Nakasone T, Taira Y, Arakaki Y, Nakamoto T, Wakayama A, Ooyama T, Maemoto H, Heianna J, Aoki Y.
    Br J Radiol; 2017 Aug 30; 90(1076):20170241. PubMed ID: 28707541
    [Abstract] [Full Text] [Related]

  • 17. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL, Yuan KS, Wu SY.
    Head Neck; 2017 Jul 30; 39(7):1364-1370. PubMed ID: 28370614
    [Abstract] [Full Text] [Related]

  • 18. Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
    Nagasaka M, Zaki M, Issa M, Kim H, Abrams J, Sukari A.
    Laryngoscope; 2017 Oct 30; 127(10):2260-2264. PubMed ID: 28271529
    [Abstract] [Full Text] [Related]

  • 19. Regional control after concomitant chemoradiotherapy without planned neck dissection in node-positive head and neck squamous cell carcinomas.
    Sakashita T, Homma A, Oridate N, Suzuki S, Hatakeyama H, Kano S, Mizumachi T, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.
    Auris Nasus Larynx; 2013 Apr 30; 40(2):211-5. PubMed ID: 22867524
    [Abstract] [Full Text] [Related]

  • 20. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A, Huang SH, Xu W, Granata R, Liu CS, Waldron JN, Chen E, Ringash J, Bayley A, Chan KK, Hope AJ, Cho J, Razak AA, Hansen A, Jang R, Perez-Ordonez B, Weinreb I, Bossi P, Orlandi E, Licitra LF, Song Y, O'Sullivan B, Siu LL, Kim J.
    Eur J Cancer; 2016 Nov 30; 67():174-182. PubMed ID: 27669504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.